У нас вы можете посмотреть бесплатно Committee Insights | 3.1.22 | Cannabis and COVID-19 - What We Know and What We Don’t или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
In this edition of our NCIA Committee Insights series originally aired on Tuesday, March 1, 2022 members of NCIA’s Scientific Advisory Committee convened a panel of leading clinical, regulatory and cannabis technology experts to lead a very timely discussion surrounding cannabis and COVID-19. This webinar gave an overview of the effects of COVID-19 on the body with a discussion on the research related to cannabis based treatments. Presentation Slide Deck: https://bit.ly/3tjbcvi Learning Objectives: • Learn about COVID-19 and how it infects the mammalian body’s organ systems. • Discuss the endocannabinoid systems role in the immune response and how research supports its role in COVID-19. • Outline implications of cannabinoid treatments based on available research including the most recent acidic cannabinoid study that has been all over the media. • Identify areas of interest for future research. Speakers: Dr. Paloma Lehfeldt, MD, MA Senior Director of Clinical Science and Partnerships Goodness Growth Holdings Lucy Postolov Owner and President Cannapy Health LLC / Postolova Acupuncture Group, Inc. Bryant Godfrey Partner Foley Hoag Jim Makoso Director / CEO Lucid Lab Group / Flowe Technology